T cells can effectively combat tumors by generating immunomodulatory antibodies after immune system activation [38], while immunotherapy for cancer treatment is based on the activation of tumor-reactive CD4+ and CD8+ T cells [39]. This evidence concerns the gene CD4 and neoplasm.